DAVID LAU, PhD

Senior Vice President, Development Sciences

David is Senior Vice President, Development Sciences at Nura Bio, and oversees preclinical and early clinical development activities at the company. David has more than 30 years of experience in preclinical and clinical drug development across large pharmaceutical and biotech companies including Foresee Pharmaceuticals, Rigel Pharmaceuticals, Johnson & Johnson, Amgen and Sandoz where he has contributed to progressing both small molecule and biologics programs from discovery through proof-of-concept clinical studies. 

David graduated with an undergraduate degree in Pharmaceutics from the State University of New York at Buffalo. He earned his graduate degree in Pharmaceutical Chemistry from the University of California, San Francisco, focusing his research on pharmacokinetics, pharmacodynamics, and drug metabolism.